PLAU and COVID-19: In turn, STAT3 and PAI-1 augmented thrombosis and coagulopathy in COVID-19 possibly by effectively suppressing urokinase-type Plasminogen Activator (uPA) and tissue-type Plasminogen Activator (tPA) (Figure 4) (158–160).